Get the Stockscreener App
0.6484
2.90%
0.0183
Pre-market:
.65
0.0016
+0.25%
Dariohealth Corp stock is traded at $0.6484, with a volume of 77,527.
It is up +2.90% in the last 24 hours and down -0.23% over the past month.
DarioHealth Corp is a digital therapeutics (DTx) company delivering personalized evidence-based interventions that are driven by precision data analytics, software, and personalized coaching. Its cross-functional team operates at the intersection of life sciences, behavioral science, and software technology to deliver seamlessly integrated and engaging digital therapeutics interventions. Also platform and suite of solutions deliver personalized and dynamic interventions driven by data analytics and one-on-one coaching for diabetes, hypertension, weight management, musculoskeletal pain, and behavioral health.
See More
Previous Close:
$0.6301
Open:
$0.632
24h Volume:
77,527
Relative Volume:
0.12
Market Cap:
$24.89M
Revenue:
$20.35M
Net Income/Loss:
$-59.43M
P/E Ratio:
-0.6295
EPS:
-1.03
Net Cash Flow:
$-30.96M
1W Performance:
-10.69%
1M Performance:
-0.23%
6M Performance:
-31.60%
1Y Performance:
-59.98%
1-Day Range:
$0.622
$0.6623
1-Week Range:
$0.6102
$0.7864
52-Week Range:
$0.56
$1.9298
Dariohealth Corp Stock (DRIO) Company Profile
Name
Dariohealth Corp
Sector
Industry
Phone
972-4-770-6377
Address
322 W 57TH ST. #33B, NEW YORK
Compare DRIO with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
DRIO
Dariohealth Corp
|
0.6484 | 24.89M | 20.35M | -59.43M | -30.96M | -1.03 |
|
VEEV
Veeva Systems Inc
|
227.80 | 36.98B | 2.75B | 714.14M | 1.09B | 4.33 |
|
SOLV
Solventum Corp
|
72.30 | 12.51B | 8.26B | 66.00M | 1.17B | 0.3682 |
|
DOCS
Doximity Inc
|
60.80 | 11.41B | 516.85M | 174.11M | 217.38M | 0.87 |
|
HQY
Healthequity Inc
|
93.97 | 8.14B | 1.15B | 96.70M | -161.99M | 1.09 |
|
TEM
Tempus Ai Inc
|
42.16 | 7.26B | 640.44M | -743.28M | -206.93M | -11.29 |
Dariohealth Corp Stock (DRIO) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-29-25 | Downgrade | TD Cowen | Buy → Hold |
| May-13-22 | Upgrade | Alliance Global Partners | Neutral → Buy |
| Apr-22-21 | Initiated | Cowen | Outperform |
| Mar-23-21 | Initiated | Stifel | Buy |
| Feb-25-21 | Initiated | Cantor Fitzgerald | Overweight |
| Feb-01-21 | Downgrade | Alliance Global Partners | Buy → Neutral |
| Aug-17-20 | Initiated | Aegis Capital | Buy |
| Aug-29-17 | Initiated | Aegis Capital | Buy |
| May-09-16 | Initiated | Rodman & Renshaw | Buy |
View All
Dariohealth Corp Stock (DRIO) Latest News
DarioHealth Appoints New Auditing Firm PwC Member - TipRanks
DarioHealth (NASDAQ:DRIO) Price Target Lowered to $2.00 at Stifel Nicolaus - Defense World
Stifel cuts DarioHealth stock target to $2, maintains buy rating - Investing.com
Stifel cuts DarioHealth stock target to $2, maintains buy rating By Investing.com - Investing.com UK
DarioHealth Corp. (NASDAQ:DRIO) Q4 2024 Earnings Call Transcript - Insider Monkey
DarioHealth revenue increases 32.9% to USD 27M in 2024 - Medical Buyer
DarioHealth Reports Strong Revenue Growth in 2024 - TipRanks
Market News Alert: DarioHealth Beats Q4 Expectations, Reports 398% Growth in B2B Recurring Revenue - sharewise
Earnings call transcript: DarioHealth Q4 2024 beats EPS expectations By Investing.com - Investing.com Canada
Earnings call transcript: DarioHealth Q4 2024 beats EPS expectations - Investing.com India
DarioHealth Corp reports results for the quarter ended December 31Earnings Summary - TradingView
DarioHealth earnings beat by $0.15, revenue topped estimates - Investing.com
DARIOHEALTH Earnings Results: $DRIO Reports Quarterly Earnings - Nasdaq
DarioHealth Expects To Realize Additional 20% Reduction In Operating Expenses Between Q4 2025 & Q4 2025 - Marketscreener.com
DarioHealth Q4 Earnings: Revenue Jumps 110%, B2B2C Channel Drives Growth - StockTitan
DarioHealth to Report Fourth Quarter and Full Year 2024 Results on Monday, March 10, 2025 - Marketscreener.com
DarioHealth Corp. SEC 10-K Report - TradingView
DarioHealth Corp. to Host Earnings Call - ACCESS Newswire
Dario Expands Behavioral Health Offerings to Include a Provider Network Through Strategic Arrangement with Rula - GuruFocus.com
Can DarioHealth's 15,000-Provider Network Deal Transform Digital Mental Health Access? - StockTitan
DarioHealth (DRIO) Expected to Announce Earnings on Monday - Defense World
DarioHealth adds major healthcare system to client roster By Investing.com - Investing.com South Africa
DarioHealth adds major healthcare system to client roster - Investing.com
Can DarioHealth's Entry Into Healthcare Provider Market Transform Its Growth Trajectory? - StockTitan
DarioHealth expands board with healthcare veteran Larry Leisure By Investing.com - Investing.com Australia
DarioHealth Appoints Lawrence Leisure to Board of Directors - TipRanks
Investor Network Invites You to the DarioHealth Third Quarter 2017 Earnings Conference Call and Webcast Live on Tuesday, November 14, 2017 - ACCESS Newswire
DarioHealth Corp. Appoints Lawrence B. Leisure to its Board of Directors -February 27, 2025 at 08:30 am EST - Marketscreener.com
Investor Network Invites You to the DarioHealth Second Quarter 2017 Earnings Conference Call and Webcast Live on Monday, August 14, 2017 - ACCESS Newswire
DarioHealth Appoints Larry Leisure To Board - citybiz
DarioHealth expands board with healthcare veteran Larry Leisure - Investing.com India
DarioHealth Appoints Healthcare Industry Leader Larry Leisure to Board of Directors - PR Newswire
DarioHealth (NASDAQ:DRIO) Stock Price Passes Below Two Hundred Day Moving Average – What’s Next? - Defense World
DarioHealth Corp Inc. (DRIO) Price Performance: The Role of Volume and Liquidity - The InvestChronicle
DarioHealth Corp (DRIO)’s stock price range in the last year - US Post News
DarioHealth adds new Blue Cross Blue Shield to payer network - MSN
DarioHealth Corp (DRIO) rating downgrades by TD Cowen - Knox Daily
DarioHealth stock hits 52-week low at $0.63 amid market challenges - MSN
DarioHealth Corp. (DRIO) Expands Health Plan Reach with New Blue Cross Blue Shield Agreement - Insider Monkey
How does DRIO’s price to cash per share ratio compare in the market? - US Post News
Market News Alert: DarioHealth Secures Significant New Agreement, Expanding Growth in the $1.2 Trillion Dollar Cardiometabolic Market - sharewise
DarioHealth Gains on Deal with Blue Cross - Baystreet.ca
Market News Alert: DarioHealth Secures Significant New Agreement, Expanding Growth in the $1.2 Trillion Dollar Cardiometabolic Market | FinancialContent Business Page - Financial Content
DarioHealth inks deal with Blue Cross Blue Shield By Investing.com - Investing.com Nigeria
DarioHealth inks deal with Blue Cross Blue Shield - MSN
DarioHealth Announces New Blue Cross Blue Shield Agreement, Expanding Health Plan Client Base - Financial Times
Comparing DarioHealth (NASDAQ:DRIO) and PROCEPT BioRobotics (NASDAQ:PRCT) - Defense World
DarioHealth (NASDAQ:DRIO) Stock Rating Lowered by TD Cowen - Defense World
Dariohealth Corp Stock (DRIO) Financials Data
Revenue
Net Income
Cash Flow
EPS
5.27%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):